• 2351 Citations
  • 26 h-Index
20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Song Zhang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

DC-HIL/GpNMB is a negative regulator of tumor response to immune checkpoint inhibitors

Chung, J. S., Ramani, V., Kobayashi, M., Fattah, F., Popat, V., Zhang, S., Cruz, P. D., Gerber, D. E. & Ariizumi, K., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1449-1459 11 p.

Research output: Contribution to journalArticle

  • Glycine by MR spectroscopy is an imaging biomarker of glioma aggressiveness

    Tiwari, V., Daoud, E. V., Hatanpaa, K. J., Gao, A., Zhang, S., An, Z., Ganji, S. K., Raisanen, J. M., Lewis, C. M., Askari, P., Baxter, J., Levy, M., Dimitrov, I., Thomas, B. P., Pinho, M. C., Madden, C. J., Pan, E., Patel, T. R., DeBerardinis, R. J., Sherry, A. D. & 4 others, Mickey, B. E., Malloy, C. R., Maher, E. A. & Choi, C., Jul 7 2020, In : Neuro-oncology. 22, 7, p. 1018-1029 12 p.

    Research output: Contribution to journalArticle

  • HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma

    Courtney, K. D., Ma, Y., de Leon, A. D., Christie, A., Xie, Z., Woolford, L., Singla, N., Joyce, A., Hill, H., Madhuranthakam, A. J., Yuan, Q., Xi, Y., Zhang, Y., Chang, J., Fatunde, O., Arriaga, Y., Frankel, A. E., Kalva, S., Zhang, S., McKenzie, T. & 8 others, Torras, O. R., Figlin, R. A., Rini, B. I., McKay, R. M., Kapur, P., Wang, T., Pedrosa, I. & Brugarolas, J., Feb 15 2020, In : Clinical Cancer Research. 26, 4, p. 793-803 11 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer

    Gerber, D. E., Camidge, D. R., Morgensztern, D., Cetnar, J., Kelly, R. J., Ramalingam, S. S., Spigel, D. R., Jeong, W., Scaglioni, P. P., Zhang, S., Li, M., Weaver, D. T., Vaikus, L., Keegan, M., Horobin, J. C. & Burns, T. F., Jan 2020, In : Lung Cancer. 139, p. 60-67 8 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Reduced Physical Activity Levels in Children after a First Episode of Acute Venous Thromboembolism

    Zia, A., Yang, Z., Zhang, S. & Babb, T., Apr 2020, In : Journal of Pediatrics. 219, p. 229-235.e2

    Research output: Contribution to journalArticle